Iterum Therapeutics(ITRM) - 2024 Q2 - Earnings Call Transcript

Iterum Therapeutics plc (NASDAQ:ITRM) Q2 2024 Results Conference Call August 14, 2024 8:30 AM ET Company Participants Louise Barrett - Senior Vice President of Legal Affairs & Secretary Corey Fishman - President, CEO & Director Judith Matthews - Chief Financial Officer Conference Call Participants Jason McCarthy - Maxim Group Operator Good morning, everyone. Welcome to Iterum Therapeutics Second Quarter 2024 Financial Results and Business Update. My name is Kiki, and I will be your conference operator today ...